Literature DB >> 1704660

Biological characterization of infectious molecular clones derived from a human immunodeficiency virus type-1 isolate with rapid/high replicative capacity.

R Fredriksson1, P Stålhanske, A von Gegerfelt, B Lind, P Aman, E Rassart, E M Fenyö.   

Abstract

In order to molecularly characterize rapidly and slowly replicating HIV-1 variants, molecular clones were obtained from a rapid/high virus isolate. This isolate, 4803, had only been passaged in peripheral blood mononuclear cells (PBMC) prior to cloning. Molecular cloning was done in bacteriophage lambda-dash using high molecular weight DNA of isolate 4803 infected PBMC. Seven recombinant phages were identified. The clones were found to be related to each other and differed only at 1 or 2 restriction sites (out of 28). The molecular clones were transfected into various cell types by electroporation. The phenotype of progeny viruses was found to be dependent on the cell type used for transfection. Progeny viruses produced by PBMC cultures differed from the parental isolate in that they did not form syncytia and lacked the capacity to replicate in cell lines. Since transfection of PBMC yielded progeny viruses within 1 week, this phenotype is considered to be the true phenotype of the clones. Transfection of the T-lymphoid HUT-78 cell line and of the monocytoid U937-2 cell line yielded progeny viruses after considerable delay (more than 1 month). Progeny viruses from HUT-78 cells were similar to the parental isolate in that they formed syncytia in PBMC and replicated in all cell lines tested. Progeny viruses from U937-2 cells showed an intermediate phenotype in that they replicated in U937-2 but not in T-lymphoid cell lines. These results indicate that molecular clones of a rapid/high virus may have a restricted replicative capacity compared to the parental, genetically heterogenous virus isolate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704660     DOI: 10.1016/0042-6822(91)90469-r

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1.

Authors:  K Fujita; J Silver; K Peden
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase.

Authors:  K Nagy; M Young; C Baboonian; J Merson; P Whittle; S Oroszlan
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.

Authors:  R L Willey; M A Martin; K W Peden
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

Review 4.  Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Authors:  Jean-Charles Grivel; Robin J Shattock; Leonid B Margolis
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

5.  Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.

Authors:  Immaculate L Nankya; Denis M Tebit; Awet Abraha; Fred Kyeyune; Richard Gibson; Oyebisi Jegede; Gabrielle Nickel; Eric J Arts
Journal:  AIDS Res Ther       Date:  2015-10-03       Impact factor: 2.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.